Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M702751200 on July 18, 2007

J. Biol. Chem., Vol. 282, Issue 37, 26696-26706, September 14, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/37/26696    most recent
M702751200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dimitrov, J. D.
Right arrow Articles by Vassilev, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dimitrov, J. D.
Right arrow Articles by Vassilev, T. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Antibodies Use Heme as a Cofactor to Extend Their Pathogen Elimination Activity and to Acquire New Effector Functions*Formula

Jordan D. Dimitrov{ddagger}§||12, Lubka T. Roumenina**1, Virjinia R. Doltchinkova{ddagger}{ddagger}, Nikolina M. Mihaylova{ddagger}, Sebastien Lacroix-Desmazes§||, Srinivas V. Kaveri§||, and Tchavdar L. Vassilev{ddagger}3

From the {ddagger}Department of Immunology, Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria, the **Department of Biochemistry, Sofia University, St. Kliment Ohridsky, 1164 Sofia, Bulgaria, the {ddagger}{ddagger}Department of Biophysics and Radiobiology, Sofia University, St. Kliment Ohridski, 1164 Sofia, Bulgaria, §Centre de Recherche des Cordeliers, Université Pierre et Marie Curie-Paris 6, UMR S 872, F-75006 Paris, France, Université Paris Descartes, UMR S 872, F-75006 Paris, France, and ||INSERM, U872, F-75006 Paris, France

Various pathological processes are accompanied by release of high amounts of free heme into the circulation. We demonstrated by kinetic, thermodynamic, and spectroscopic analyses that antibodies have an intrinsic ability to bind heme. This binding resulted in a decrease in the conformational freedom of the antibody paratopes and in a change in the nature of the noncovalent forces responsible for the antigen binding. The antibodies use the molecular imprint of the heme molecule to interact with an enlarged panel of structurally unrelated epitopes. Upon heme binding, monoclonal as well as pooled immunoglobulin G gained an ability to interact with previously unrecognized bacterial antigens and intact bacteria. IgG-heme complexes had an enhanced ability to trigger complement-mediated bacterial killing. It was also shown that heme, bound to immunoglobulins, acted as a cofactor in redox reactions. The potentiation of the antibacterial activity of IgG after contact with heme may represent a novel and inducible innate-type defense mechanism against invading pathogens.


Received for publication, March 30, 2007 , and in revised form, July 10, 2007.

* This work was supported by Howard Hughes Medical Institute Grant 55000340 and by INSERM and CNRS, France. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Experimental Procedures, Refs. 1–5, and Figs. S1–S4.

This paper is dedicated to the memory of Dr. Jean-Pierre Bouvet.

1 Both authors contributed equally to this work.

3 Howard Hughes Medical Institute International Research Scholar. To whom correspondence may be addressed. Tel.: 359-2-979-6348; Fax: 359-2-870-0109; E-mail: vassilev{at}microbio.bas.bg.

2 To whom correspondence may be addressed: Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Academy G. Bonchev St., Block 26, 1113 Sofia, Bulgaria. Tel.: 359-2-979-6348; Fax: 359-2-870-0109; E-mail: jdd{at}microbio.bas.bg or jd.dimitrov{at}gmail.com.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement